Navigation Links
Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions
Date:5/6/2008

The Hemobag(R) prevents wastage by saving the patient's own whole blood

SOMERS, Conn., May 6 /PRNewswire/ -- A recent paper in a journal for perfusionists, the health professionals who manage patients on heart and lung bypass machines during open heart surgery, reports how Global Blood Resources' online waste calculator can be used to estimate the cost of blood wastage seen with the "cell washing" machines most commonly used during heart surgery to salvage the patient's own blood for autotransfusion. Such wastage usually requires transfusion of increasingly costly blood components donated by others (allogeneic blood), the very type of riskier transfusion that blood salvage machines were designed to prevent. The GBR calculator exposes how this previously unknown wastage can cost billions of dollars each year, money that could be saved by using Global Blood Resources' salvage device, the Hemobag(R).

Although the tainted blood scandals of the 1980s and 1990s are largely over thanks to improved blood donor screening tests for diseases such as AIDS and hepatitis C, discouraging news still abounds. News reports commonly feature severe blood shortages and research that documents newly recognized transfusion risks such as how older stored blood may put heart surgery patients at increased risk. In response, the medical community has moved to manage blood usage by minimizing transfusion of donated blood and instead saving and transfusing the patient's own blood that would otherwise be lost during surgery and is by far the best choice. Cardiovascular heart disease is still the leading cause of death in America. To help correct this each day approximately a thousand people in the U.S. alone have heart surgery, with over 325,000 cases annually and growing 5% each year. Blood salvage has been used extensively in cardiac surgery, which historically has been a major user of the nation's blood supply, consuming between 15-20% of the blood transfused in the United
'/>"/>

SOURCE Global Blood Resources LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...ANTIPOLIS, France, February 26 NicOx,S.A. (NYSE E...results for,full year 2008 and provided an overvie...ivities for naproxcinod, its lead investigational,...f osteoarthritis (OA). , Michele Garufi, Chief...e,NicOx has entered 2009 in its strongest strategi...
...o understand friction on a very small scale, a tea... to think big. , Friction is a force that affect...tact; the more surface contact there is, the stron...f a meter friction can wreak havoc on tiny device...les. With their high surface-to-volume ratio, nano...
... Feb. 25 Cornerstone Therapeutics Inc. (Nasdaq: ...d on developing and commercializing prescription m...ced that it will host a conference call at 8:30 AM...nancial results for the quarter and year ended Dec...pdate on the Company,s strategy, operations and pr...
Other Biology Technology:Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 2Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 4Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 5Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 6Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 7Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 8Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 9Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 10Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 11Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 12Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 13Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 14Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 15Models present new view of nanoscale friction 2Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 2Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 3Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 4
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient,s future risk of death, according to published studies. Now, results of a ne
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Somanetics Corporation to Release Third Quarter 2009 Financial Results and Host Conference Call September 17 2009 13830 1Somanetics Corporation to Release Third Quarter 2009 Financial Results and Host Conference Call September 17 2009 13830 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America 56126 1RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America 56126 2
...ading life scientists from Europe and around the w...ar Biology Organization (EMBO) for their proven ex..., distinguished as EMBO Members, are from Europe a...pected scientists come from other parts of the wor...rent membership total to 1360. , Membership is a ...
... Research , a journal of the American Association ...nicotine in breast tumor development and metastase...Beth Israel Deaconess Medical Center, is among the...ry cells. , "Although numerous studies indicate ...little is known about the effect of nicotine on br...
...other planets and in extreme environments on Earth...y initiative under a five-year grant from NASA,s A... Earth and Beyond." , Christopher H. House, assoc...isciplinary team to develop methods to detect and ...in relevant ecosystems in ancient rocks and other ...
Other Biology News:EMBO honors 59 leading life scientists 2Study links nicotine with breast cancer growth and spread 2Penn State receives new NASA astrobiology grant 2Penn State receives new NASA astrobiology grant 3
Criterion Staining and Blotting Trays, with lids, 12 from Bio-Rad
...orating a wide range of next-generation features i... standard for flexible laboratory solutions. It pu...tting, dilution, dispensing, and integrations int... flexible as it is efficient and economical. The B...
...ek FX P is the latest entry in the Biomek line. W... positional accuracy and increased robustness, it ...It can be configured with either one or two pipett... FX P sets the standard for flexible laboratory s...
BD Falcon 96-well Flat-bottom ELISA Plates from BD Biosciences - Discovery Labware
Biology Products: